| Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF JP Bassand, G Accetta, AJ Camm, F Cools, DA Fitzmaurice, KAA Fox, ... European heart journal 37 (38), 2882-2889, 2016 | 301 | 2016 |
| May Measurement Month 2019: the global blood pressure screening campaign of the International Society of Hypertension T Beaney, AE Schutte, GS Stergiou, C Borghi, D Burger, F Charchar, ... Hypertension 76 (2), 333-341, 2020 | 212 | 2020 |
| International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: results from the GARFIELD-AF, ORBIT-AF I, and ORBIT … BA Steinberg, H Gao, P Shrader, K Pieper, L Thomas, AJ Camm, ... American heart journal 194, 132-140, 2017 | 190 | 2017 |
| Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry S Haas, H Ten Cate, G Accetta, P Angchaisuksiri, JP Bassand, AJ Camm, ... PloS one 11 (10), e0164076, 2016 | 175 | 2016 |
| Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without … KAA Fox, JE Lucas, KS Pieper, JP Bassand, AJ Camm, DA Fitzmaurice, ... BMJ open 7 (12), e017157, 2017 | 146 | 2017 |
| Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: rationale for comprehensive management of atrial fibrillation JP Bassand, G Accetta, W Al Mahmeed, R Corbalan, J Eikelboom, ... PloS one 13 (1), e0191592, 2018 | 117 | 2018 |
| Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation GYH Lip, SK Rushton-Smith, SZ Goldhaber, DA Fitzmaurice, ... Circulation: Cardiovascular Quality and Outcomes 8 (2_suppl_1), S12-S20, 2015 | 95 | 2015 |
| Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry JP Bassand, S Virdone, SZ Goldhaber, AJ Camm, DA Fitzmaurice, ... Circulation 139 (6), 787-798, 2019 | 89* | 2019 |
| Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: real-world data from the GARFIELD-AF registry S Oh, S Goto, G Accetta, P Angchaisuksiri, AJ Camm, F Cools, S Haas, ... International journal of cardiology 223, 543-547, 2016 | 76 | 2016 |
| Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ... Journal of the American Heart Association 8 (3), e010510, 2019 | 62 | 2019 |
| Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF S Haas, AJ Camm, JP Bassand, P Angchaisuksiri, F Cools, R Corbalan, ... American heart journal 213, 35-46, 2019 | 59 | 2019 |
| Evolving quality standards for large-scale registries: the GARFIELD-AF experience KAA Fox, BJ Gersh, S Traore, A John Camm, G Kayani, A Krogh, ... European Heart Journal–Quality of Care and Clinical Outcomes 3 (2), 114-122, 2017 | 46 | 2017 |
| Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation: a report from the GARFIELD-AF registry R Corbalan, JP Bassand, L Illingworth, G Ambrosio, AJ Camm, ... JAMA cardiology 4 (6), 526-548, 2019 | 39 | 2019 |
| Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry FWA Verheugt, H Gao, W Al Mahmeed, G Ambrosio, P Angchaisuksiri, ... European heart journal 39 (6), 464-473, 2018 | 38 | 2018 |
| Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry AJ Camm, G Accetta, W Al Mahmeed, G Ambrosio, SZ Goldhaber, S Haas, ... BMJ open 7 (3), e014579, 2017 | 37 | 2017 |
| Диастолическая сердечная недостаточность ЕП Свищенко, ЕА Матова Сердечная недостаточность 1, 47-54, 2009 | 35 | 2009 |
| Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: insights from the GARFIELD‐AF registry C Jerjes‐Sanchez, R Corbalan, ACP Barretto, HL Luciardi, J Allu, ... Clinical cardiology 42 (5), 553-560, 2019 | 31 | 2019 |
| Артериальная гипертензия у особых категорий больных ВН Коваленко, ЕП Свищенко Киев: Морион 374, 2009 | 31 | 2009 |
| Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry F Cools, B Wollaert, G Vervoort, S Verstraete, J Voet, K Hermans, A Heyse, ... Acta Cardiologica, 2018 | 24 | 2018 |
| Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation … KAA Fox, G Accetta, KS Pieper, JP Bassand, AJ Camm, DA Fitzmaurice, ... European Heart Journal-Quality of Care and Clinical Outcomes 4 (1), 27-35, 2018 | 23 | 2018 |
Larysa MishchenkoState Institution National Scientific Center Institute of Cardiology named after M.D.StrazheskoVerified email at bigmir.net
